নাইজেরিয়া - ইংরেজি - NAFDAC (National Agency for Food and Drugs Administration and Control)

cypermethrin 10%

মিশর - ইংরেজি - EDA (Egyptian Drug Authority)

f.hoffman la roche-scientific office - tablet - 7.5 mg

সিঙ্গাপুর - ইংরেজি - HSA (Health Sciences Authority)

dksh singapore pte. ltd. - capecitabine - tablet, film coated - 150 mg - capecitabine 150 mg

সিঙ্গাপুর - ইংরেজি - HSA (Health Sciences Authority)

dksh singapore pte. ltd. - capecitabine - tablet, film coated - 500 mg - capecitabine 500 mg

সিঙ্গাপুর - ইংরেজি - HSA (Health Sciences Authority)

roche singapore pte. ltd. - midazolam maleate 10.2mg eqv. to midazolam - tablet, film coated - 7.5mg

সিঙ্গাপুর - ইংরেজি - HSA (Health Sciences Authority)

dksh singapore pte. ltd. - midazolam maleate 20.40 mg eqv. to midazolam - tablet, film coated - 15 mg - midazolam maleate 20.40 mg eqv. to midazolam 15 mg

বাহরাইন - ইংরেজি - الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين

al jishi pharmacy - midazolam maleate - film coated tablet - 15

ফিলিপাইন - ইংরেজি - FDA (Food And Drug Administration)

zuellig pharma corporation; distributor: zuellig pharma corporation - midazolam - film-coated tablet - 15 mg

ফিলিপাইন - ইংরেজি - FDA (Food And Drug Administration)

roche (philippines) inc.; distributor: zuellig pharma corporation - midazolam (as maleate) - tablet - 15mg

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

rare disease therapeutics, inc - centruroides fab2 antivenin (equine) (unii: dda050fcea) (centruroides fab2 antivenin (equine) - unii:dda050fcea) - centruroides fab2 antivenin (equine) 24 mg in 1 ml - anascorp® [centruroides (scorpion) immune f(ab')2 (equine) injection] is an equine-derived antivenom indicated for treatment of patients with clinical signs of scorpion envenomation. none. risk summary animal reproduction studies have not been conducted with anascorp. it is also not known whether anascorp can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. anascorp should be given to a pregnant woman only if clearly needed. risk summary it is not known whether anascorp is excreted in human breast milk. because many drugs are excreted in human milk, caution should be exercised when anascorp is administered to a nursing woman. seventy-eight percent of the patients enrolled in the clinical studies were pediatrics subjects(1204/1534), with ages ranging from less than one month to 18.7 years of age. patient age groups were as follows: < 2 years of age, 29%, 2 to 5 years, 37%, 5 to 18 years, 34%. the efficacy and safety